Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Distler

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Scientific Reports|December 15, 2020
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung diseaseC Meier, K Freiburghaus, C Bovet, et al.
Arthritis and Rheumatism|October 3, 2000
HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian menN C Lambert, O Distler, U Müller-Ladner, et al.
Rheumatology (Oxford, England)|January 4, 2001
Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseasesA Pickenpack, R H Straub, O Distler, et al.
Rheumatology International|January 29, 2000
Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosisO Distler, B Rinkes, U Hohenleutner, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Gene transfer of protective cytokines in rheumatoid arthritisO Distler, C A Seemayer, T Pap, et al.
Scandinavian Journal of Rheumatology|February 8, 2012
Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) databaseC Foocharoen, O Distler, M Becker, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trialP Janiak, M Thumshirn, D Menne, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritisJ Schedel, O Distler, M Woenckhaus, et al.
Nature Medicine|December 1, 2001
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemiaJ S Liang, O Distler, D A Cooper, et al.
Arthritis Research & Therapy|March 27, 2020
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysisLukas Bütikofer, Pierre A Varisco, O Distler, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Scientific Reports|December 15, 2020
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung diseaseC Meier, K Freiburghaus, C Bovet, et al.
Arthritis and Rheumatism|October 3, 2000
HLA-DQA1*0501 is associated with diffuse systemic sclerosis in Caucasian menN C Lambert, O Distler, U Müller-Ladner, et al.
Rheumatology (Oxford, England)|January 4, 2001
Safety and efficacy of an intravenous loading dose of azathioprine for treatment of non-TPMT-deficient patients with rheumatic diseasesA Pickenpack, R H Straub, O Distler, et al.
Rheumatology International|January 29, 2000
Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosisO Distler, B Rinkes, U Hohenleutner, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Gene transfer of protective cytokines in rheumatoid arthritisO Distler, C A Seemayer, T Pap, et al.
Scandinavian Journal of Rheumatology|February 8, 2012
Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) databaseC Foocharoen, O Distler, M Becker, et al.
Alimentary Pharmacology & Therapeutics|October 20, 2007
Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trialP Janiak, M Thumshirn, D Menne, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Discrepancy between mRNA and protein expression of tumour suppressor maspin in synovial tissue may contribute to synovial hyperplasia in rheumatoid arthritisJ Schedel, O Distler, M Woenckhaus, et al.
Nature Medicine|December 1, 2001
HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: a potential mechanism for protease inhibitor-induced hyperlipidemiaJ S Liang, O Distler, D A Cooper, et al.
Arthritis Research & Therapy|March 27, 2020
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysisLukas Bütikofer, Pierre A Varisco, O Distler, et al.
Pageof 10